Atlantic Fellow at GBHI, UCSF Memory and Aging Center
Home Country: USA
Field of Employment: Animal Therapy & Training
Key areas: dementia patient care, caregiver support, animal behavior, animal assisted therapies, community engagement and education
Adam Waskow comes to GBHI with a deep understanding of the human–animal bond after spending many years in the service dog industry. He believes strongly in the capability of animals and people to work together for their mutual benefit, having seen this connection flourish in thousands of his past clients.“Animals and humans have been helping each other thrive for centuries. Using science and technology, we can look more deeply at this relationship and its potential to help those with neurological diseases.”
Inspired by his work with the visually impaired, Waskow is now focused on neurodegenerative disease. He is applying his skillset to learn how animal assisted therapies and interventions could affect care and improve outcomes in a variety of environments and applications. As a GBHI fellow, his research will focus primarily on the use of therapy dogs working with dementia patients and their caregivers. He looks forward to working at GBHI, believing in the combined power of collaboration, interdisciplinary learning, and solid research to improve outcomes.
Bio: Adam Waskow has spent the last 25 years working with service dogs and people in need. He started his work at Guide Dogs for the Blind (GDB) in 1991 and became board certified as a licensed Guide Dog Mobility Instructor in 1993. Holding several key leadership positions throughout his tenure at GDB, he was a prominent force in the organization’s development and direction. and he helped to design and implement vital programs, initiatives, and improvements. For several years, he focused primarily on innovating and developing solutions for the client and dog teams during their most crucial periods of instruction. In 2014, he founded Memory Dog Inc., a nonprofit dedicated to exploring the use of highly trained dogs for people with neurodegenerative diseases.
© 2017 All rights reserved